Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Travel Vaccines Market Grown from 2024 to 2025?

In recent years, the market size for travel vaccines has seen a robust growth. It is projected to expand from $4.73 billion in 2024 to $5.14 billion in 2025, marking a compound annual growth rate (CAGR) of 8.6%. This growth during the historical period can be linked to factors such as more people traveling internationally, government health initiatives for travelers, the spread of diseases due to globalization, rising awareness among travelers, and the growth of the travel and tourism industry.

What Growth Rate Is Anticipated for the Travel Vaccines Market in the Coming Years?

The market size of travel vaccines is anticipated to experience substantial growth in the forthcoming years, escalating to $7.49 billion in 2029 with a compound annual growth rate (CAGR) of 9.9%. The predicted growth during the forecast period can be ascribed to factors such as an increased rate of business travel, the emergence of infectious disease risks, regulatory mandates and entry prerequisites by the government, a surge in demand for unique travel destinations, and partnerships between government entities and pharmaceutical firms. The forecast period is expected to witness trends like customized vaccination approaches, market extension into areas previously not affected, the embracement of digital health technologies, regulatory backing, expedited approvals, and innovative advancements.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

Who Are the Leading Companies in the Travel Vaccines Market?

Major companies operating in the travel vaccines market include Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.

What Are the Key Drivers of the Travel Vaccines Market?

The growth of the travel vaccine market is anticipated to be driven by the surge in travel and tourism. Travel and tourism encompass the movement of individuals and objects, facilitated by various modes of transportation such as trains, ships, aircraft, and other vehicles, across different distant geographic locations. Travel vaccines offer protection to tourists and travelers, ensuring their health and safety during their overseas journeys. For example, the United Nations World Tourism Organization (UNWTO), an intergovernmental tourism promotion agency based in Spain, reported in January 2023 that over 900 million tourists traveled internationally in 2022, a figure twice that of 2021 and 63% higher than before the pandemic. Consequently, the uptick in travel and tourism is fueling the expansion of the travel vaccine market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11918&type=smp

What Are the Key Market Segments in the Travel Vaccines Industry?

The travel vaccines market covered in this report is segmented –

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,

2) By Composition: Mono Vaccines, Combination Vaccines

3) By Booking Channel: Online Booking, In-Person Booking

4) By Application: Domestic Travel, Outbound Travel

Subsegments:

1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines

2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)

3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines

4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine

5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines

6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine

7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)

8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine

9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

What Are the Latest Trends in the Travel Vaccines Market?

The travel vaccine market is seeing a surge in product innovation, with key players making strides in developing new vaccines to maintain market domination. For instance, Takeda Pharmaceutical Company Limited, a pharmaceutical firm based in Japan, obtained approval in August 2022, for its innovative QDENGA (Dengue Tetravalent Vaccine) (TAK-003) from the Indonesia National Agency for Drug and Food Control. This vaccine aims to prevent dengue fever caused by any serotype in individuals aged 6 to 45, offering comprehensive protection against dengue disease and hospitalization, with efficacy lasting three years post-immunization, irrespective of previous exposure to the disease.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

What Are the Key Regional Markets in the Travel Vaccines Industry?

North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11918

This Report Delivers Insight On:

1. How big is the travel vaccines market, and how is it changing globally?

2. Who are the major companies in the travel vaccines market, and how are they performing?

3. What are the key opportunities and risks in the travel vaccines market right now?

4. Which products or customer segments are growing the most in the travel vaccines market?

5. What factors are helping or slowing down the growth of the travel vaccines market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model